FDA Warns of Amputations Connected to Certain Diabetes Drugs

Posted by Firm Staff on Jun 15, 2017 10:48:27 AM

Serious side effects, including leg, foot, and other amputation, have been associated with a new class of diabetes drugs known as SGLT-2 inhibitors. Accordingly, the FDA has required black boxed warnings for amputation risks for glucose-controlling medications such as Invokana.

Read More

Topics: Health News, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Amputation, Amputation Compensation, Amputation Attorney, Amputation Law, Amputation Lawyer, Amputation Lawsuit, Leg Amputation, Leg Amputation Compensation, Leg Amputation Attorney, Leg Amputation Law, Leg Amputation Lawyer, Leg Amputation Lawsuit, Foot Amputation, Foot Amputation Compensation, Foot Amputation Attorney, Foot Amputation Law, Foot Amputation Lawyer, Foot Amputation Lawsuit, Invokana, Invokana Compensation, Invokana Attorney, Invokana Law, Invokana Lawyer, Invokana Lawsuit, Diabetes Drug, Diabetes Drug Lawsuit, Type 2 Diabetes, Type 2 Diabetes Medication, Diabetes Medication, SGLT-2 Inhibitors, SGLT-2 Inhibitors Lawsuit

$2.2 Billion Offered to Settle Actos Lawsuits

Posted by Firm Staff on Sep 2, 2016 3:26:29 PM

Takeda Pharmaceutical Co., the manufacturer of Actos, proposed $2.2 billion to settle thousands of lawsuits, according to Bloomberg. As of April 2015 more than 8,000 lawsuits had been filed against the diabetes medicine claiming hidden cancer risks.

Read More

Topics: Health, FDA, Actos, Actos Lawsuit, Diabetes, Diabetes Drug, Diabetes Drug Lawsuit, Ryan Foster, Foster & Houston, The Law Offices of Foster & Houston, FANDHLAW

Contact Foster & Houston

More to Read